These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29983282)

  • 1. Forewords BMC.
    Gallou F
    Bioorg Med Chem; 2018 Aug; 26(14):4329. PubMed ID: 29983282
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling chirality in enzymatic synthesis.
    Hodgson J
    Biotechnology (N Y); 1992 Oct; 10(10):1093-7. PubMed ID: 1368788
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug industry looks to the lab instead of rainforest and reef.
    Service RF
    Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
    [No Abstract]   [Full Text] [Related]  

  • 4. High-throughput and parallel screening methods in asymmetric hydrogenation.
    Jäkel C; Paciello R
    Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
    [No Abstract]   [Full Text] [Related]  

  • 5. Race for molecular summits.
    Service RF
    Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the reactions used for the preparation of drug candidate molecules.
    Carey JS; Laffan D; Thomson C; Williams MT
    Org Biomol Chem; 2006 Jun; 4(12):2337-47. PubMed ID: 16763676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 8. Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.
    Peake DA; Ackermann BL
    J Am Soc Mass Spectrom; 2005 Apr; 16(4):599-605. PubMed ID: 15871168
    [No Abstract]   [Full Text] [Related]  

  • 9. Large-scale oxidations in the pharmaceutical industry.
    Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
    Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
    [No Abstract]   [Full Text] [Related]  

  • 10. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palladium coupling catalysts for pharmaceutical applications.
    Doucet H; Hierso JC
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):672-90. PubMed ID: 17987520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From genes to products: innovations in drug discovery.
    Afshar M
    Drug Discov Today; 2003 May; 8(9):392-4. PubMed ID: 12706655
    [No Abstract]   [Full Text] [Related]  

  • 13. Preface: Additive manufacturing in pharmaceutical product design.
    Rantanen J; Fatouros DG
    Adv Drug Deliv Rev; 2021 Nov; 178():113991. PubMed ID: 34582829
    [No Abstract]   [Full Text] [Related]  

  • 14. Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges.
    Douroumis D; Nokhodchi A
    Adv Drug Deliv Rev; 2017 Aug; 117():1-2. PubMed ID: 29103527
    [No Abstract]   [Full Text] [Related]  

  • 15. Crystal structures of drugs: advances in determination, prediction and engineering.
    Datta S; Grant DJ
    Nat Rev Drug Discov; 2004 Jan; 3(1):42-57. PubMed ID: 14708020
    [No Abstract]   [Full Text] [Related]  

  • 16. Organic synthesis in flow for medicinal chemistry.
    Wirth T
    Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554
    [No Abstract]   [Full Text] [Related]  

  • 17. Starting from scratch.
    Chapman T
    Nature; 2004 Jul; 430(6995):113. PubMed ID: 15229610
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry.
    Caille S; Cui S; Faul MM; Mennen SM; Tedrow JS; Walker SD
    J Org Chem; 2019 Apr; 84(8):4583-4603. PubMed ID: 30916557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent In Silico Resources for Drug Design and Discovery.
    Veljkovic N
    Curr Med Chem; 2019; 26(21):3836-3837. PubMed ID: 31584358
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.